CAPTRUST Financial Advisors’s Surmodics SRDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-2,307
Closed -$86K 3791
2022
Q2
$86K Hold
2,307
﹤0.01% 2326
2022
Q1
$105K Buy
2,307
+451
+24% +$19.7K ﹤0.01% 2232
2021
Q4
$89K Buy
1,856
+28
+2% +$1.41K ﹤0.01% 2245
2021
Q3
$102K Buy
1,828
+1,274
+230% +$70.8K ﹤0.01% 2062
2021
Q2
$30K Buy
554
+400
+260% +$21.9K ﹤0.01% 2843
2021
Q1
$9K Buy
+154
New +$7.68K ﹤0.01% 3496

Other funds holding SRDX

CAPTRUST Financial Advisors's SRDX Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of Surmodics (SRDX) in Q3 2022, closing a stake of 2,307 shares — an estimated $86K sold.

CAPTRUST Financial Advisors first reported a position in SRDX in Q1 2021 and held it in 6 quarters. The position peaked at $105K in Q1 2022. 123 funds tracked by Wall St. Rank hold SRDX as of Q3 2022.

  • CAPTRUST Financial Advisors reported no remaining Surmodics position as of Q3 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 2,307 Surmodics shares in Q3 2022, an estimated $86K.
  • CAPTRUST Financial Advisors first reported a position in Surmodics in Q1 2021 and held it in 6 quarters.
  • CAPTRUST Financial Advisors's Surmodics position peaked at $105K in Q1 2022.
  • 123 funds tracked by Wall St. Rank held Surmodics as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.